Company ProfilePremium

Heraeus

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Heraeus - Chemicals & Materials showcase

Year Founded & Workforce

1660

15,115 Employees

Industry

Chemicals & Materials
Heraeus logo

Heraeus Employee Contacts

154 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Heraeus Overview

Heraeus is a family-owned German technology group that turns materials science into positions in precious metals, medical technology, semiconductor and electronics materials, and industrial measurement. Its headline revenue of EUR 43.2 billion in FY2025 is dominated by pass-through precious metal trading, so management steers the business on revenue excluding precious metals of EUR 2.83 billion, which places it among mid-sized specialty materials groups. Within the semiconductor supply chain it supplies packaging materials such as bonding wire, solder and sinter pastes, high-purity quartz and ceramic components for fab equipment, conductive polymers, and precious metal recycling and refining that returns metal from electronics and semiconductor scrap. Its strategic strengths are a low-leverage balance sheet, long-term family ownership and a position across the entire precious metal cycle. Its central challenge is restoring trust after customer-detrimental irregularities at its Hanau recycling operation, which remain under criminal investigation.

In its FY2025 Financial Report, Heraeus describes itself as "a family-owned global technology group headquartered in Hanau", with roots in a family pharmacy dating to 1660 and a position as one of the leading providers in its global sales markets. These markets include electronics, semiconductors, telecommunications, automotive, chemicals, medical technology, pharmaceuticals and steel. Activities are bundled in four Business Areas: Precious Metals, Healthcare, Semiconductor & Electronics, and Industrials. Heraeus Holding sets overarching strategy, and "preserving the long-term independence of the Group" has priority in all corporate decisions.

Independently characterized, Heraeus is two businesses reported as one. The first is a high-volume, low-margin metal flow: trading, hedging, leasing, refining and recycling, where revenue moves with metal prices and volatility. Group revenue rose 46.9% in FY2025 mainly for this reason. The second is a portfolio of specialty franchises with strong technical barriers: bone cement, contract manufacturing of medical components, quartz glass, electronic materials and steel sensors. Metal revenue is why the Group's EBIT margin on total revenue (about 1%) carries no information. The margin on revenue excluding precious metals, 15.8% in FY2025, is the meaningful measure.

The revenue model is overwhelmingly product-based, with service-like income in precious metals. Recycling revenue is recognized over time until the customer is reimbursed for its metal, and it includes non-cash consideration: reclaimed metal that remains with Heraeus after agreed quantities are returned. That consideration was EUR 178.1 million in FY2025 and is the largest single explanation for the Precious Metals revenue jump. Heraeus does not disclose subscription or licensing revenue, and the FY2025 report says total service proceeds within revenue are insignificant.

Value-chain position: Characterization: Mid-chain: buys processed metals and chemicals, sells semi-finished materials and components to OEMs and Tier 1 suppliers; in precious metals it spans refining, trading, processing and recycling

Customer types: Characterization: Mining houses, refiners, banks and investors; chemical and pharmaceutical producers; semiconductor device, packaging and equipment makers; fiber manufacturers and hyperscalers; hospitals and medical OEMs; steel and foundry producers

End-markets: Characterization: Electronics, semiconductors, telecommunications and AI data centers, automotive, chemicals, hydrogen, aerospace propulsion, pharmaceuticals, medical technology, steel, luxury and investment metals

Precious metals value-chain stages: Characterization: Six stages: raw material extraction, refining, trading and administration, processing, use phase, recycling; Heraeus operates in four of them

Revenue types: Characterization: Metal trading and metal-bearing product revenue; revenue excluding precious metals from products and services; recycling fees and non-cash metal consideration

Semiconductor exposure sits mainly in Semiconductor & Electronics (EUR 793.6 million revenue excluding precious metals in FY2025), through Heraeus Electronics, Heraeus Covantics, Heraeus Epurio and Heraeus Printed Electronics, with a second leg in Precious Metals through probing alloys and recycling. In the recycling market, the company takes in precious-metal-bearing materials from electronics, including powders, pastes and production residues from sectors such as LEDs, photovoltaics and passive components. It operates 12 recycling facilities in eight countries, including associated companies.

Strategy

The Heraeus Vision published with the FY2024 report sets the framing. Its identity statement reads: "We are a family-owned, global technology company. With responsible leadership and technology we enable sustainable transformation towards a healthy planet and society." Its priorities are:

  • value creation through the success of Operating Companies, with market leadership, customer focus, innovation, excellence, digitalization and scalability as levers

  • growth and resilience through entrepreneurial investments, partnerships and deep understanding of technologies

  • people, with integrity, leadership, talent development and performance culture

  • commitment to sustainability and responsibility

The claim is "Materials. Innovations. For Generations."

In FY2025 management developed a concrete target picture for Heraeus in 2030, with strategic guidelines and fields of action: succeed with strong Operating Companies on shared principles, strengthen innovation as the central growth driver, and use technologies such as artificial intelligence deliberately. No numeric 2030 financial targets are public.

Governance reset: Date: 2025; Content: Business Area heads on the Board; GELT replaces GMC

Compliance overhaul: Date: 2025–2026; Content: Integrity Office reports to CEO with independent right to present to the Supervisory Board; Legal and Compliance separated; Group Compliance Committee; integrity initiative

Heraeus Innovation System: Date: 2025; Content: Group framework for promoting and steering innovation; expert career paths

Listening Tour: Date: 2025; Content: CEO dialogue with staff; engagement surveys with comparable questions

Top 100 leadership program: Date: 2025; Content: Inclusive leadership and speak-up culture

Portfolio pruning: Date: 2025–2026; Content: Exits from solar pastes, BASF JV, aiXscale, Remloy, semiconductor chemicals, B2C retail

Precious metals reorganization: Date: July 2026; Content: Separate Operating Companies for industrial business and for luxury and investment

Hollow core fiber industrialization: Date: 2025 onward; Content: Heraeus Covantics plans about 100 times more fibers a year for Microsoft than the current market offers, and expects triple-digit million euro sales over three years

Group AI and Digital Office: Date: July 2026; Content: Group AI Officer Sarah Lewandowski, reporting to the Chief Transformation Officer

Hanau Infra Upgrade: Date: Ongoing; Content: Investments over EUR 50 million in staged heat and grid renewal, saving more than 4,000 tCO2 a year

Climate targets: Date: Ongoing; Content: 42% Scope 1 and 2 cut by 2030; 37.5% Scope 3 cut by 2035; 50% renewable electricity by 2030

The strategic direction is simplification. Since 2023 Heraeus has sold businesses that were either subscale, volume-driven or lacking an owner advantage, while buying small, complementary technology. Large M&A has not recurred since Norwood. The new CEO's background in Zeiss and electronics fits a more technology-led, operating-company-driven model, while the immediate management load remains compliance and integrity.

Products & Services

Pricing is not publicly disclosed for any industrial product line. Precious-metal-bearing products are typically priced as a metal value plus a fabrication charge, and recycling is priced through fees and contractual metal return terms.

Precious Metals

Healthcare

Semiconductor & Electronics

Industrials

Product Portfolio

OfferingDescriptionTarget customerNotes

Precious metal trading

Physical and derivative trading from Hanau, New York, Hong Kong and Shanghai, plus Mendrisio; leasing and hedging

Industrial users, banks, miners

Metal on loan from third parties EUR 3,583.0M at end-2025

PGM recycling and refining

Recovery from spent catalysts, electronics scrap and production waste; wet chemical and pyrometallurgical routes

Chemical, automotive, glass, electronics customers

12 facilities in eight countries including associates; expansion at Santa Fe Springs and Hanau in 2025

Circlear

Products from 100% recycled precious metals; TÜV SÜD verified on a mass-balance basis for seven metals

Customers seeking low-carbon metals

Launched April 2024

Catalysts

Chemical process catalysts, aniline catalysts, catalytic gauzes

Chemical producers

Higher aniline volumes forecast for 2026

Space propulsion catalysts

Catalysts for space propellants

Aerospace

Named growth item in the 2026 outlook

Hydrogen Systems

Iridium-based catalysts and materials for electrolysis

Electrolyzer makers

Capacity expansion under way

PGM Fabrications

Bushings and related fabricated parts

Glass fiber and glass producers

High demand forecast for 2026

Probing alloys

Special precious metal alloys for semiconductor wafer testing

Probe card makers

Named demand driver for 2026

Pharmaceutical ingredients

Platinum-based APIs for oncology; business outside South America acquired from Umicore in 2025

Pharma

Contract development and manufacturing activities

Precious colors and coatings

Decorative and functional metal preparations

Ceramics, glass, luxury

Long-standing line since the 1890s

AGXX

Antimicrobial surface technology using oxygen and moisture, without releasing active ingredients

Textiles, filters

Partnerships being pursued internationally

Iridium recovery from MMO electrodes

McCol Metals process

Electrochemical industry

Acquired 2024

Investment bars, coins, luxury semi-finished goods

Argor-Heraeus, Mendrisio

Banks, watchmakers, jewelers

New minted bar design in 2026

Direct retail (Goldstore, heraeus-gold.de, scrap purchase)

Consumer channel

Private customers

Being closed; operations end 30 November 2026

OfferingDescriptionTarget customerNotes

PALACOS bone cements

Antibiotic-loaded and plain PMMA bone cements

Orthopedic surgeons, hospitals

Heraeus reported as supplying about 82% of the UK market

COPAL bone cements

Dual-antibiotic cement line

Revision surgery, infection management

Affected by the 2026 packaging issue

Calcium phosphate bone substitutes

INNOTERE range

Orthopedics

Acquired January 2025

Synthecure

Pure calcium sulfate bone substitute

Orthopedics

Acquired June 2025

Heraeus Medevio components

Precious metal and other components, cables, catheters, delivery systems, neuromodulation, cardiac

Medical OEMs

Sites in Germany, USA, Costa Rica, Puerto Rico, Czech Republic, Singapore

Norwood Medical

Precision instruments and components for minimally invasive, orthopedic and robot-assisted surgery

Medical OEMs

About 1,200 employees; 100th anniversary 2026

MO-SCI

Specialty and bioactive glass particles, medical and industrial glass, nuclear vitrification and refinery glass

OEMs, research, industry

Bekeson Glass capabilities added June 2025

Engineered Tissue Solutions

Bioactive glass wound care

Wound care providers

US-based

OfferingDescriptionTarget customerNotes

Bonding wires

Gold, silver and copper-based wires

Semiconductor packaging

China activities via Heraeus Zhaoyuan JV-type entities

Solder pastes

Fine-pitch and LED solder pastes

Electronics assembly

R&D focus in 2025

mAgic PE340 and PE360 sinter pastes

Silver pressure sinter; PE360 offers at least 200 W/mK and SiC module attach above 150°C

Power modules, automotive

PE360 received a 2025 Global Technology Award; PE340 marked new at PCIM 2026

Microbond solder preforms

Module attach preforms using Innolot alloy; Innolot 2.0 reduces silver content

IGBT modules up to 150°C junction

Marked new at PCIM 2026

Die Top System (DTS)

Integrated die-top material system; company claims tenfold power cycling capability

Power electronics

New materials shown 2025

Metal ceramic substrates

Substrates for power electronics

Power modules

Ongoing R&D

Thermal interface materials

TIM for electronics

Data center, power

R&D focus

Heating elements

Non-precious metal thick-film heaters

Appliances, industry

R&D focus

High-purity quartz and fused silica

Tubes, rods, plates, cylinders; process tubes and components for fab equipment

Semiconductor equipment makers

Heraeus Covantics; Smart Plates semi-finished line launched 2025

Lithography quartz

Quartz for optical and EUV applications

Lithography supply chain

Weak EUV demand in 2025; EUR 25.0M impairment

Ceramic components

Technical ceramics for chip manufacture

Equipment makers

Named growth opportunity

Telecom fiber materials

Synthetic cylinders and tubes for preforms

Fiber makers

Demand driven by AI data centers in the USA

Hollow Core Fiber

Air-core optical fiber; up to 47% faster than solid fiber per the Group's description

Microsoft and hyperscale networks

Scaling in Europe and the USA

Multicore fibers and specialty fibers

Next-generation preforms and fibers

Data center, medical, laser

R&D focus

Clevios

Conductive polymers (Heraeus Epurio)

Capacitors, displays, sensors

Epurio exceeded EUR 100M revenue for the first time

Semiconductor chemicals

Photoacid generators, photo-initiators, monomers

Photoresist makers

Sold to Brewer Science, August 2026

Prexonics, PriElex and related

Selective metallization and thick film (Heraeus Printed Electronics)

Semiconductor packaging

PriElex line acquired from Kayaku Advanced Materials, 2024

OfferingDescriptionTarget customerNotes

Temperature, oxygen and sample probes

Disposable sensors for molten steel, iron and aluminum

Steel mills, foundries

Core franchise of Heraeus Electro-Nite

Automated measurement systems

Robotic and non-contact measurement

Steel mills

7 Steel UK project saves over 150 work hours a year and raises yield by 5%

Falcon

Oxygen measurement inside electric arc furnaces

EAF steelmakers

Featured innovation in 2026

Smart Steel Technologies

AI-based process optimization

Steel producers

Minority stake (46.55%), written down in FY2025

Financial Narrative

All figures are from the Heraeus Financial Reports FY2021 to FY2025, on the latest restated basis. Heraeus is a GmbH and does not publish earnings per share or dividends per share.

Two restatements apply. FY2022 was restated for a change to FIFO for trading inventories. Profit after tax was originally reported as EUR 499.4 million. FY2023 was restated for the recycling irregularities. Profit after tax was originally reported as EUR 444.2 million, and year-end equity as EUR 4,681.0 million.

Income statement

Revenue excluding precious metals compounded at 5.6% a year from FY2021 to FY2025, and total revenue at 10.0%. The compound figure flatters organic momentum: the FY2021 base predates Norwood Medical, and portfolio disposals then removed revenue in 2023 and 2025. Revenue excluding precious metals peaked at EUR 2,899.8 million in FY2022, and FY2025 remains below that level.

Profitability fell sharply after FY2022. The FY2022 peak benefited from strong metal prices and EUR 137.5 million of income from the Zimmer Biomet settlement. FY2023 included EUR 111.6 million of disposal income. FY2024 carried a EUR 50.1 million goodwill impairment on Norwood Medical and weaker PGM prices. FY2025's recovery is low quality. EBIT includes EUR 178.1 million of non-cash consideration and EUR 157.8 million of provision reversals, offset by EUR 80.3 million of impairments and EUR 76.9 million of write-downs on revalyu and Smart Steel Technologies. Management states that, without the special effects, FY2025 earnings would have declined and the forecast would have been missed.

Balance sheet

Net debt is financial debt, including leases, less cash and time deposits. It excludes pensions of EUR 303.7 million and metal on loan from third parties, which is not recognized on the balance sheet and reached EUR 3,583.0 million at end-2025, up from EUR 2,316.0 million. The metal lease line matters: it is a funding source that is off balance sheet and repriced sharply when lease rates spiked in 2025.

The equity decline in FY2025 reflects EUR 281.3 million of negative currency translation, chiefly the weaker US dollar, which outweighed the year's profit. The equity ratio was 56.7%, against 59.5% a year earlier.

Cash flow

Free cash flow is operating cash flow less capital expenditure. FY2025 operating cash flow more than halved, because inventories absorbed EUR 348.6 million at high metal prices, receivables absorbed EUR 146.2 million, and provisions and pensions fell by EUR 167.0 million, mostly through customer compensation and reversals. The non-cash metal consideration boosts earnings without producing cash, which further widens the gap. The dividend paid to shareholders of Heraeus Holding fell from EUR 143.7 million, which included a special distribution following the 2024 Heraeus Share Days, to EUR 40.1 million. Capital expenditure fell 31.9%, and order commitments dropped to EUR 43.7 million from EUR 81.6 million, which suggests the investment cycle has passed its peak. Treasury share purchases are negligible (EUR 1.8 million in FY2024, none in FY2025).

Ratios

ROIC is EBIT after the effective tax rate, divided by equity plus financial debt less cash and time deposits. The cash conversion cycle uses total revenue and materials cost, including precious metals, so it reflects the trading flow more than the specialty businesses. Solvency remains very strong, but returns have fallen to about 7% from about 12% and interest cover has weakened as metal-related finance costs rose. The effective tax rate rose to 32.7% from 24.6% in FY2025.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Business Area Details

Business AreaOperating CompaniesContent

Precious Metals

Heraeus Precious Metals (industrial products, recycling, trading); Argor-Heraeus (luxury, investment)

Trading, refining, recycling, catalysts, hydrogen, pharma ingredients, bars and coins

Healthcare

Heraeus Medical; Heraeus Medevio; Norwood Medical; MO-SCI; Engineered Tissue Solutions (ETS)

Bone cement and biomaterials; medical components and contract manufacturing; specialty glass; wound care

Semiconductor & Electronics

Heraeus Electronics; Heraeus Covantics; Heraeus Epurio; Heraeus Printed Electronics

Assembly and packaging materials; quartz, fused silica and ceramics; conductive polymers; selective metallization

Industrials

Heraeus Electro-Nite

Measurement sensors and systems for molten metal

Start-ups and holdings

Heraeus Amloy; revalyu (majority holding, equity accounted); Smart Steel Technologies (minority)

Amorphous metals; PET recycling; AI for steel

Revenue excl. precious metals (EUR Mn)

Revenue excl. precious metals (EUR Mn)FY2022FY2023FY2024FY2025

Precious Metals

444.3448.8417.2575.6

Healthcare

802.6880.1901.2899.9

Semiconductor & Electronics

780.1740.6792.1793.6

Industrials

868.0790.9591.7550.1

YoY growth (%)

YoY growth (%)FY2023FY2024FY2025

Precious Metals

1.0-7.038.0

Healthcare

9.72.4-0.1

Semiconductor & Electronics

-5.17.00.2

Industrials

-8.9-25.2-7.0

Share of Group revenue excl. precious metals (%)

Share of Group revenue excl. precious metals (%)FY2023FY2024FY2025

Precious Metals

15.715.420.3

Healthcare

30.833.231.8

Semiconductor & Electronics

25.929.228.0

Industrials

27.621.819.4

Field of activity, revenue excl. precious metals (EUR Mn)

Field of activity, revenue excl. precious metals (EUR Mn)FY2021FY2022

Health

458.4782.1

Electronics

531.3686.6

Industrials

690.2759.2

Environmental

591.8667.1

Income Statement

Metric (EUR Mn)FY2021FY2022FY2023FY2024FY2025

Total revenue

29,506.429,082.225,649.229,396.943,193.9

Revenue excl. precious metals

2,272.52,899.82,861.92,711.32,830.4

Gross result (revenue less materials)

1,972.82,309.92,314.82,160.82,230.5

EBITDA

714.2956.4797.4600.3759.7

EBIT

523.5695.2571.7319.9446.0

Profit before tax

495.9684.4547.3313.6385.3

Profit after tax

369.3504.6410.8236.5259.2

Margin on revenue excl. precious metals (%)

Margin on revenue excl. precious metals (%)FY2021FY2022FY2023FY2024FY2025

Gross result margin

86.879.780.979.778.8

EBITDA margin

31.433.027.922.126.8

EBIT margin

23.024.020.011.815.8

Net margin

16.317.414.48.79.2

Balance Sheet

Metric (EUR Mn)FY2021FY2022FY2023FY2024FY2025

Total assets

6,993.57,152.27,465.67,906.28,156.6

Cash and cash equivalents

649.9934.51,108.01,172.71,151.8

Time deposits

00128.090.048.0

Current financial debt

597.565.4165.9140.8139.8

Non-current financial debt

182.7674.0689.8695.1694.4

Total financial debt

780.2739.4855.7835.9834.2

Net debt (negative = net cash)

130.3-195.1-380.3-426.8-365.6

Shareholders' equity

3,801.44,541.24,493.64,703.14,621.0

Goodwill

500.4527.4482.8484.6453.9

Other intangible assets

535.0519.4454.3443.3379.9

Current assets

3,970.74,025.04,139.04,443.75,026.5

Current liabilities

2,265.81,400.01,718.31,997.62,366.6

Working capital

1,704.92,625.02,420.72,446.12,659.9

Cash Flow

Metric (EUR Mn)FY2021FY2022FY2023FY2024FY2025

Operating cash flow

608692634563257

Capital expenditure

248288360335228

Free cash flow

36040427422829

Distributions paid

46.145.1112.0150.846.3

Payments for acquisitions

909.49.032.431.333.7

Interest paid

42.749.849.250.097.8

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE on year-end equity (%)

9.711.19.15.05.6

ROA on year-end assets (%)

5.37.15.53.03.2

ROIC (%)

9.911.810.45.67.1

Current ratio (x)

1.752.882.412.222.12

Debt to equity (x)

0.210.160.190.180.18

Net debt to EBITDA (x)

0.18-0.20-0.48-0.71-0.48

EBIT to interest paid (x)

12.314.011.66.44.6

Asset turnover on total revenue (x)

4.224.073.443.725.30

Asset turnover on revenue excl. metals (x)

0.320.410.380.340.35

Cash conversion cycle (days)

29.427.831.426.621.3

Share of revenue excl. precious metals (%)

Share of revenue excl. precious metals (%)FY2021FY2022FY2023FY2024FY2025

Germany

1411111112

Europe excl. Germany

2021212122

Americas

2632343434

Asia

3835323130

Africa and Australia

22232

Dividend paid to shareholders of Heraeus Holding (EUR Mn)

Dividend paid to shareholders of Heraeus Holding (EUR Mn)FY2024FY2025

Dividend paid in year

143.740.1

Capital Instruments

InstrumentAmountCouponMaturity

Heraeus Finance bond

EUR 500.0M

2.625%

June 2027

Registered bond

EUR 50.0M

3.75%2032

Registered bond

EUR 50.0M

3.75%2034

KfW loan

EUR 0.7M

0.95%

March 2026

Contractual cash flows at 31 December 2025 (EUR Mn)

2,0262,027

2028–2030

Bonds

5.8513.10

Registered bonds

1.43.811.3

Liabilities to banks

128.84.524.4

Lease liabilities

19.215.227.2

Analyst Conclusions

Management guidance for 2026 (FY2025 Financial Report)

Group revenue excl. precious metals: Expectation: Moderate increase

Precious Metals: Expectation: Strong rise, on higher non-cash consideration, propulsion and aniline catalyst volumes, new customers, hydrogen and bushings

Healthcare: Expectation: Slight rise; first-half supply bottleneck

Semiconductor & Electronics: Expectation: Moderate increase; AI strong, autos stagnant, lithography stable, fiber strong

Industrials: Expectation: Slight decline, chiefly currency

EBIT, EBT, profit after tax: Expectation: Strong increase

EBITDA: Expectation: Substantial increase

The portfolio exits of semiconductor chemicals and Remloy will reduce revenue modestly in the second half. There is no consensus estimate because the company is private.

Bull case

  1. Hollow core fiber becomes a new growth engine. Heraeus expects triple-digit million euro sales over three years, against an S&E base of EUR 793.6 million, and one of the world's largest cloud operators is a committed customer.

  2. Net cash of EUR 365.6 million, a Baa1 rating and low capital commitments allow Heraeus to absorb the remaining EUR 300.0 million provision and still invest.

  3. A focused portfolio under a technology-oriented CEO could bring margins back from 15.8% towards the 20%-plus earned through FY2023, particularly as Healthcare recovers and impairments fall away.

Bear case

  1. Trust is a recycling refiner's product. A negative LBMA outcome, indictments or customer loss would hit the most metal-intensive profit pool, and the investigation's second part is unfinished.

  2. Underlying earnings are weaker than reported. Management's own statement is that adjusted results missed the forecast, and free cash flow was only EUR 29 million.

  3. Structural pressure persists. China competes in fiber, quartz, electronics and steel, R&D and patent counts are falling, and EUV-related impairments suggest slower lithography demand.

Key catalysts in the next 12 months

LBMA Incident Review outcome: Timing: Open; Why it matters: Access to Good Delivery market

Prosecutor decisions: Timing: Open; Why it matters: Legal and reputational closure

Completion of second investigation part: Timing: Open; Why it matters: Size of final provision

Sanctions proceedings: Timing: Open; Why it matters: Fine exposure

FY2026 Financial Report: Timing: Mid-2027; Why it matters: Test of earnings recovery and cash conversion

Hollow core fiber ramp: Timing: 2026–2027; Why it matters: Proof of AI growth story

Bond refinancing: Timing: Before June 2027; Why it matters: Funding signal

Goldstore wind-down, HPM permanent leadership: Timing: To Q1 2027; Why it matters: Organizational completion

Decision on SBTi target update: Timing: Open; Why it matters: Climate credibility

Analyst verdict

Heraeus is financially sound but operationally and reputationally in transition. The balance sheet is the kind that only long-term family ownership tends to produce: net cash, an equity ratio of 56.7%, and undrawn facilities. That strength has bought the company time to deal with the most serious crisis in its modern history without external pressure. It should not obscure the deterioration underneath. Return on invested capital has fallen by around five percentage points since FY2022. Free cash flow was negligible in FY2025. The year's profit growth depended on provision reversals and non-cash recycling consideration.

The Hanau affair matters more than its provision suggests. The Precious Metals business is built on customers trusting Heraeus with metal that belongs to them, and the company has conceded that warnings went unheeded. The structural response has been real: a reformed Board, a stronger Integrity Office, a new CFO and Chief Compliance Officer, and a split of the precious metals business. The remedy is still unproven, and three external processes remain open.

For the semiconductor supply chain, Heraeus remains a relevant materials and recycling partner, though a narrower one after selling sputtering targets and semiconductor chemicals. Its forward semiconductor story now rests on packaging materials, quartz, ceramics and the fiber that connects AI data centers, while its recycling position rests on metal know-how that few rivals can match.

The investment case hinges on whether FY2026 shows clean earnings and cash conversion alongside a clean resolution of the legal matters. If both occur, the portfolio is more focused and better governed than at any time in a decade. If either fails, the balance sheet still protects the company, but rating pressure and customer attrition would become the central issue. The overall assessment is stable credit with a cautious operating outlook, pending evidence.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleTenureBackground

Dr. Frank Stietz

CEO, Chairman, Labor Director

CEO since 23 May 2025; Board since March 2020

Born 1966; diploma in experimental physics, University of Kassel and Montana State; doctorate and habilitation in physics, MBA; Carl Zeiss 2000–2015, including head of Corporate Research and Technology; President Heraeus Electronics from 2015; President Norwood Medical 2022–2023; elected to the Jenoptik Supervisory Board in 2026

Barbara Gregor

CFO

Since 1 January 2026

Succeeded Rolf Wetzel, who left 30 September 2025

Dr. Klemens Brunner

Managing Director, Semiconductor & Electronics and Industrials

Board since 15 August 2025

Former President of Heraeus Electronics

Dr. Steffen Metzger

Managing Director, Precious Metals

Board since 15 August 2025

Also CEO of Heraeus Precious Metals; both precious metals companies report to him

Heiko Specht

Managing Director, Healthcare

Board since 15 August 2025

Healthcare leadership

Executive Leadership Team

NameRole

Dr. Martina Gieg

Chief Human Resources Officer

Deniz Serifsoy

Chief Transformation Officer

Helge Heindl

General Counsel

Nicole Ebenau

Chief Compliance Officer since 1 February 2026; previously at Porsche and CARIAD

Helena Hallwas

Head of Corporate Audit, permanent guest

Board of Directors — Franz Haniel

NameRole

Franz Haniel

Chairman

Alexander Wiesbach

Vice Chairman since June 2026

Jasmin Atessacan

Member, elected June 2026

Dr. Simone Bagel-Trah

Member

Dr. Hans-Tjabert Conring

Member; Chairman of the Shareholders' Committee

Birgit Heraeus-Roggendorf

Member

Dr. Hubert Lienhard

Member

Annette Lukas

Member

Florian Pieroth

Member

Dr. Mohsen Sohi

Member since 1 February 2025

Christian Stübing

Member

Dr. Kathrin Wissel-Stoll

Member, elected June 2026

Major Shareholders

Holder (FY2025 Financial Report, 31 December 2025)Stake

EVG Tertio GmbH & Co. KG

Predominant share of capital, without significant voting rights; exact percentage not publicly disclosed

Voting shares

Dispersed among a number of shareholders; individual stakes not publicly disclosed

Competitive Landscape

Competitors by Segment

BusinessCompetitorsPositioning

PGM recycling and refining

Umicore, Johnson Matthey, BASF, TANAKA, DOWA Eco-System, JX Advanced Metals

Heraeus is among the largest; strongest in Hanau, China and across trading

Gold and silver refining

MKS PAMP, Valcambi, Metalor, Rand Refinery

Argor-Heraeus is one of the large Swiss refineries

Semiconductor materials recycling

RS Technologies, KINIK, Mimasu, Phoenix Silicon, Pure Wafer, Solar Applied Materials, Umicore, TANAKA

Heraeus competes in metals, not wafer reclaim

Bonding wire and packaging materials

TANAKA, Nippon Micrometal, MK Electron, Indium Corporation, MacDermid Alpha, Senju, Henkel

Long-standing wire and paste franchise, price pressure from China

Quartz and fused silica

Shin-Etsu (partly a JV partner), Tosoh Quartz, Momentive Technologies, Corning, Ferrotec

Technology leader in high-purity glass, exposed to Chinese price pressure

Hollow core fiber

Corning, YOFC, Linfiber, Microsoft Azure Fiber in-house design

Named partner of Microsoft

Bone cement

Stryker, Zimmer Biomet, Tecres, Smith+Nephew

Market leader in the UK with about 82% share

Medical contract manufacturing

Integer, Viant, Cirtec, Resonetics, Jabil Healthcare

Mid-sized specialist

Steel sensors

Vesuvius, Minteq, Chinese local suppliers

Global category specialist

Conductive polymers

Agfa, Solvay-origin businesses, Asian suppliers

Clevios is a recognized brand

Peer Comparison FY2025

CompanyFiscal yearComparable revenueGrowth (%)Operating margin (%)

Heraeus

FY2025

EUR 2,830M excl. metals

4.415.8

Umicore

FY2025

EUR 3.6bn excl. metal

3

16.5 (adjusted EBIT)

Johnson Matthey

FY to Mar 2026

GBP 2,555M excl. metals

-10

13.3 (underlying)

Materion

FY2025

USD 1,046M value-added

-4.7

10.5 (operating profit)

Integer

FY2025

USD 1,854M sales

8.0

11.9 (GAAP)

Recent Developments

The HPM reorganization came with an explicit statement that no job cuts or site closures are planned. FY2025 saw headcount reductions in Semiconductor & Electronics in response to market conditions, and additions in Healthcare in Costa Rica.

Company Snapshot

$48,696.6M

Revenue

15,115

Employees

1660

Founded

Hanau, Germany

Headquarters

SWOT Analysis

Strengths

  • Financial strength: Net cash of EUR 365.6M; equity ratio 56.7%; liquidity reserves EUR 1,199.8M at end-2025
  • Undrawn funding: Commercial paper program and syndicated line unused at end-2025
  • Full metal cycle: Trading, refining, processing and recycling; 12 recycling facilities in eight countries
  • Healthcare franchise: EUR 899.9M revenue, largest Business Area; about 82% UK share in bone cement
  • Family ownership: Long-term priority on independence; no market pressure
  • AI-linked position: Microsoft partnership; triple-digit million euro sales expected from HCF over three years

Weaknesses

  • Compliance failures: EUR 300.0M provision remaining; earlier internal reports did not trigger action, by Heraeus's own admission
  • Earnings quality: FY2025 profit relied on EUR 157.8M reversals and EUR 178.1M non-cash consideration
  • Weak cash conversion: Operating cash flow EUR 257M, down 54.4%; free cash flow EUR 29M
  • Return erosion: ROIC 7.1% against 11.8% in FY2022
  • Venture losses: EUR 76.9M write-downs on revalyu and Smart Steel Technologies
  • Single-point supply risk: Packaging fault at one site halted bone cement globally

Opportunities

  • Hollow core fiber: Market forecast at 33.0% CAGR to 2036
  • AI power and connectivity: DTS, TIM, multimode and ultra-low-loss fiber demand
  • Recycling growth: Secondary PGM intake up 8.1%, gold up 22.1% in 2025 at HPM
  • Semiconductor recycling: Market forecast at USD 6.45bn by 2032
  • Medical robotics: Double-digit growth segments served by Norwood and Medevio
  • Firepower for M&A: Net cash and Baa1 rating

Threats

  • Criminal investigation: 16 suspects; 2015–2025 under review
  • LBMA review: Incident Review Process open; Good Delivery status is essential
  • Customer loss: The risk report states loss of individual customers cannot be ruled out
  • Chinese competition: Named risk in S&E, Industrials and metals
  • Metal lease costs: Finance result worsened by EUR 54.4M; EUR 3,583.0M metal on loan
  • Sanctions: Regulatory proceedings on Russia deliveries ongoing

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
23 May 2025Frank Stietz becomes CEO, succeeding Jan RinnertFirst leadership change in 12 years
5 Jun 2025Synthecure acquiredBiomaterials breadth
25 Jun 2025Bekeson Glass acquiredMO-SCI capacity
Jun 2025Induction furnaces start at Buford; Kleinostheim follows in AugustHalve furnace power to 150 kW
Jul 2025Chinese subsidiaries' sanctioned shipments via distributors end; period under review runs from July 2022 to July 2025Later voluntarily disclosed
15 Aug 2025Three Business Area heads join the BoardOperational governance
Aug 2025Investigation scope extended to adjacent process stepsSecond part of inquiry
9 Sep 2025FY2024 financial statements approvedDelayed well beyond normal timing
23 Sep 2025Microsoft hollow core fiber collaborationKey AI exposure
30 Sep 2025CFO Rolf Wetzel leavesFinance leadership gap to year-end
Oct 2025Machine failure in biomaterials packagingRoot of the 2026 cement shortage
10 Nov 2025aiXscale stake sold to Astera LabsVenture realization
Dec 2025BASF JV sale signed; Koen Rommel interim head of Electro-Nite, later confirmed as PresidentPortfolio and sanctions aftermath
1 Jan 2026Barbara Gregor becomes CFONew finance chief
23–26 Jan 2026Frankfurt prosecutors confirm probe of 16 suspects over 2015–2025Major reputational event
1 Feb 2026Nicole Ebenau becomes Chief Compliance OfficerExternal hire
10 Feb 2026Shanghai Gold Exchange adds Heraeus Limited as overseas standard gold ingot refinerMarket access expands
11–12 Feb 2026LBMA invokes Incident Review Process; Good Delivery status retainedCritical licence-to-operate issue
18 Feb 2026UK joint statement on bone cement; under seven days of UK Heraeus stock estimatedGlobal supply disruption with clinical impact
Q1 2026BASF JV sale closedExit complete
Mar 2026Andrew Williamson leaves Heraeus MedicalLeadership change amid disruption
18–29 May 2026FY2025 report finalizedProfit EUR 259.2M with one-offs
20 May 2026Remloy sale signedRare earth exit
9–11 Jun 2026mAgic PE340 and Microbond preforms shown at PCIM EuropePower electronics pipeline
13 Jun 2026Supervisory Board changes; Alexander Wiesbach Vice ChairmanBoard refresh
18 Jun 2026Semiconductor chemicals sale announcedS&E portfolio focus
1 Jul 2026HPM split; Beate Burkhart heads Epurio; Georg Levin confirmed Head of M&AOrganizational reset
15 Jul 2026Sarah Lewandowski named Group AI OfficerAI governance
3 Aug 2026Brewer Science completes acquisitionDayton exits Group
31 Aug 2026Mkango announces Remloy completionBitterfeld magnet recycling leaves Group
Sep 2026Goldstore and online shop closure announced; operations end 30 November 2026; wind-down to Q1 2027Retreat from B2C

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue Excl. Precious Metals: Precious Metals rose from EUR 444.3 Mn in FY2022 to EUR 575.6 Mn in FY2025.
Heraeus — Revenue Excl. Precious Metals
Series (EUR Mn)FY2022FY2023FY2024FY2025
Precious Metals444.3448.8417.2575.6
Healthcare802.6880.1901.2899.9
Semiconductor & Electronics780.1740.6792.1793.6
Industrials868790.9591.7550.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.